Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has The Transmucosal Drug Delivery Devices Market Size Shifted, And What Is the Outlook Through 2034?

In recent years, there has been a robust growth in the market size of transmucosal drug delivery devices. The market is set to expand from $50.24 billion in 2024 to $54.63 billion in 2025, earmarking a compound annual growth rate (CAGR) of 8.7%. Several factors have contributed to this growth during the historical period; these include the demand for immediate relief from angina, efficiency of sublingual delivery for fast absorption into the bloodstreams, the necessity to bypass gastrointestinal degradation, the creation of buccal tablets, and the need for non-invasive methods of delivering peptides and proteins.

In the upcoming years, the market for transmucosal drug delivery devices is projected to experience robust growth. The market is forecasted to reach a size of $76.06 billion by 2029, growing at a compound annual growth rate (CAGR) of 8.6%. This growth is expected due to several contributing factors such as the emergence of intelligent drug delivery systems, a rise in chronic disease prevalence, an increased emphasis on personalized medicine, an aging population requiring more medication, and heightened awareness. Key trends for this period include the widening therapeutic applications, the customization of drug delivery devices for personalized medicine, regulatory approvals and guidance, emerging markets, environmentally-friendly devices, and novel formulations.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16812&type=smp

What Are the Core Market Drivers Propelling Growth in the Transmucosal Drug Delivery Devices Industry?

The predicted increase in chronic diseases is likely to fuel the growth of the transmucosal drug delivery devices market. Chronic diseases, characterized by slow progression and duration, often require effective medical management to keep symptoms and complications in check. The rise in chronic diseases results from lifestyle factors, aging populations, environmental influences, healthcare system issues, and urbanization. Transmucosal drug delivery devices are utilized for chronic conditions to deliver controlled and effective drug doses, assuring maintained therapeutic levels for symptom control and improving adherence in patients. For example, in August 2023, the Leukemia & Lymphoma Society (LLS), a charity based in the US, reported that roughly every three minutes, a diagnosis is made for leukemia, lymphoma, or myeloma. These diagnoses were expected to total 184,720 in 2023, accounting for 9.4% of the anticipated 1,958,310 new cancer cases that year. Therefore, the escalating rates of chronic diseases propel the market growth of transmucosal drug delivery devices.

How Is the Transmucosal Drug Delivery Devices Market Segmented?

The transmucosal drug delivery devicesmarket covered in this report is segmented –

1) By Type: Passive Transdermal Drug Delivery, Active Transdermal Drug Delivery

2) By Drug Type: Buccal Tablets, Oral Sprays, Sublingual Films And Wafers, Gels, Medicated Confectionery, Other Drug Types

3) By Indication: Pain Management, Addiction Treatment, Hormonal Therapies, Others Indications

4) By End User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories, Hospitals

Subsegments:

1) By Passive Transdermal Drug Delivery: Reservoir Systems, Matrix Systems, Micro-Needle Systems, Pressure-Sensitive Adhesive Systems

2) By Active Transdermal Drug Delivery: Iontophoresis, Sonophoresis, Electroporation, Thermal Ablation, Microporation

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=16812&type=smp

Which Regions Are Driving the Next Phase of the Transmucosal Drug Delivery Devices Market Growth?

North America was the largest region in the transmucosal drug delivery devices market in 2024. The regions covered in the transmucosal drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Market Trends and Innovations Are Shaping the Future of the Transmucosal Drug Delivery Devices Industry?

Leading companies in the field of transmucosal drug delivery devices are pioneering new smart platforms including proprietary transdermal patch delivery systems. These innovative platforms boost drug absorption, increase patient adherence and make administration more convenient. A proprietary transdermal patch delivery platform is a specialized technology, owned by a particular company, designed to administer medication through the skin. It’s made to ensure a controlled release and enhance therapeutic results. For example, in January 2024, a US biotech firm, Starton Therapeutics Inc, introduced STARSILON. This is a unique proprietary transdermal patch delivery platform intended for extended use to deliver difficult-to-formulate APIs. It broadens the scope of transdermal drug delivery for challenging active pharmaceutical ingredients (APIs), improving therapeutic effectiveness through sustained delivery rates.

View the full report here:

https://www.thebusinessresearchcompany.com/report/transmucosal-drug-delivery-devices-global-market-report

How Is the Transmucosal Drug Delivery Devices Market Defined and What Are Its Core Parameters?

Transmucosal drug delivery devices are medical devices designed to deliver drugs through the mucous membranes, such as those in the mouth, nose, or rectum, for rapid absorption into the bloodstream. These devices are used to administer medications that are poorly absorbed by the gastrointestinal tract or that require quick onset of action, such as pain relief or hormone therapy. Their purpose is to bypass the digestive system, providing a more direct and efficient route for drug delivery.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16812

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model